Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.53, versus $0.67 reported last year. Revenue for the quarter came in at $610 million, versus $561 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.